Very late stent thrombosis due to des fracture: Description of a case and review of potential causes

Catheterization and Cardiovascular Interventions

Volumn 78, Issue 7, 2011, Pages 1101-1105

  Lee, Stephen W L ^a   Tam, Frankie C C ^a   Chan, Kelvin K W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ACS; acute coronary syndrome; EPC capture stent; PCI; percutaneous coronary intervention; THRM; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITRATE; RAPAMYCIN; TROPONIN I; VERAPAMIL;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTERY THROMBOSIS; ARTICLE; CASE REPORT; CORONARY ARTERY RECANALIZATION; CORONARY REPERFUSION; CORONARY STENT; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; ENDOTHELIAL PROGENITOR CELL CAPTURE STENT; HUMAN; HYPERPLASIA; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSTHESIS FAILURE; STENT FRACTURE; STENT THROMBOSIS; THROMBECTOMY;

ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTORS; SIROLIMUS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 81855184502     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23101     Document Type: Article

References (20)

1. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R,. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441. (Pubitemid 46717966)
2. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R,. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202. (Pubitemid 43929240)
3. Kim JW, Suh SY, Choi CU, Choi CU, Na JO, Kim EJ, Rha SW, Park CG, Seo HS, Oh DJ,. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus paclitaxel-eluting stent. J Am Coll Cardiol Intv 2008; 1: 65-71. (Pubitemid 351445416)
4. Kim JW, Seo HS, Park JH, Na JO, Choi CU, Lim HE, Kim EJ, Rha SW, Park CG, Oh DJ,. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: Differential recovery of coronary endothelial dysfunction. J Am Coll Cardiol 2009; 53: 1653-1659.
5. Qiao SB, Liu SW, Xu B, Chen J, Liu HB, Yang YJ, Chen JL, Gao RL,. Clinical outcomes of single stent and multiple stents in contemporary practice. Clin Cardiol 2009; 32: 33-39.
6. Park DW, Flaherty JD, Davidson CJ, Yun SCY, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SJ,. Prognostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug-eluting stent implantation in Asian patients. Am J Cardiol 2009; 103: 646-652.
7. Canan T, Lee MS,. Drug-eluting stent fracture: incidence, contributing factors, and clinical implications. Catheter Cardiovasc Interv 2010; 75: 237-245.
8. Yamada KP, Koizumi T, Yamaguchi H, Kaneda H, Bonneau HN, Honda Y, Fitzgerald PJ,. Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus-eluting stents in native coronary arteries. Int J Cardiol 2008; 130: 255-259.
9. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988; 78: 486-502.
10. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB,. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol 2009; 103: 923-929.
11. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R, Inagaki H, Toyama J, Yokota M, Murohara T,. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol 2009; 133: 321-326.
12. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, Takarada S, Kitabata H, Tanimoto T, Mizukoshi M, Imanishi T, Akasaka T,. Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation. Circ J 2009; 73: 2036-2041.
13. Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, Onuma Y, Higashikuni Y, Otsuki S, Yagishita A, Yachi S, Nakajima H, Hara K,. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 2007; 69: 380-386. (Pubitemid 46339279)
14. Lee SE, Jeong MH, Kim IS, Ko JS, Lee MG, Kang WY, Kim SH, Sim DS, Park KH, Yoon NS, Yoon HJ, Kim KH, Hong YJ, Park HW, Kim JH, Ahn YK, Cho JG, Park JC, Kang JC,. Clinical outcomes and optimal treatment for stent fracture after drug-eluting stent implantation. J Cardiol 2009; 53: 422-428.
15. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S,. Stent fracture associated with drug-eluting stents: Clinical characteristics and implications. Catheter Cardiovasc Interv 2007; 69: 387-394. (Pubitemid 46339280)
16. Chhatriwalla AK, Cam A, Unzek S, Bhatt DL, Raymond RE, Lincoff AM, Whitlow PL, Ellis SG, Tuzcu EM, Kapadia SR,. Drug-eluting stent fracture and acute coronary syndrome. Cardiovasc Revasc Med 2009; 10: 166-171.
17. Kim HS, Kim YH, Lee SW, Park DW, Lee CW, Hong MK, Park SW, Ko JK, Park JH, Lee JH, Choi SW, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Park SJ,. Incidence and predictors of drug-eluting stent fractures in long coronary disease. Int J Cardiol 2009; 133: 354-358.
18. Nakazawa G, Granada JF, Alviar CL, Tellez A, Kaluza GL, Guilhermier MY, Parker S, Rowland SM, Kolodgie FD, Leon MB, Virmani R,. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiolvasc Interv 2010; 3: 68-75.
19. Granada JF, Inami S, Aboodi MS, Tellez A, Milewski K, Wallace-Bradley D, Parker S, Rowland S, Nakazawa G, Vorpahl M, Kolodgie FD, Kaluza GL, Leon MB, Virmani R,. Development of a novel pro-healing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv 2010; 6: 257-266.
20. Co M, Tay E, Lee CH, Poh KK, Low A, Lim J, Lim IH, Lim YT, Tan HC,. Use of endothelial progenitor cell capture (Genous Bio-engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: Intermediate- to long-term clinical follow up. Am Heart J 2008; 155: 128-132. (Pubitemid 350234778)